Cargando…

BST2/Tetherin Enhances Entry of Human Cytomegalovirus

Interferon-induced BST2/Tetherin prevents budding of vpu-deficient HIV-1 by tethering mature viral particles to the plasma membrane. BST2 also inhibits release of other enveloped viruses including Ebola virus and Kaposi's sarcoma associated herpesvirus (KSHV), indicating that BST2 is a broadly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viswanathan, Kasinath, Smith, M. Shane, Malouli, Daniel, Mansouri, Mandana, Nelson, Jay A., Früh, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207899/ https://www.ncbi.nlm.nih.gov/pubmed/22072961 http://dx.doi.org/10.1371/journal.ppat.1002332

Ejemplares similares

The Great Escape: Viral Strategies to Counter BST-2/Tetherin
por: Douglas, Janet L., et al.
Publicado: (2010)

Quantitative membrane proteomics reveals a role for tetraspanin enriched microdomains during entry of human cytomegalovirus
por: Viswanathan, Kasinath, et al.
Publicado: (2017)

Ebolavirus Replication and Tetherin/BST-2
por: Yasuda, Jiro
Publicado: (2012)

Restriction of Retroviral Replication by Tetherin/BST-2
por: Hammonds, Jason, et al.
Publicado: (2012)

BST2/Tetherin Inhibition of Alphavirus Exit
por: Ooi, Yaw Shin, et al.
Publicado: (2015)

Antagonism to human BST-2/tetherin by Sendai virus glycoproteins
por: Bampi, Carole, et al.
Publicado: (2013)

Cloning and Characterization of the Antiviral Activity of Feline Tetherin/BST-2
por: Fukuma, Aiko, et al.
Publicado: (2011)

The role of BST‐2/Tetherin in host protection and disease manifestation
por: Mahauad‐Fernandez, Wadie D., et al.
Publicado: (2015)

Antagonizing the effects of Bst-2/tetherin: multiple ways to accomplish a common goal
por: Strebel, Klaus
Publicado: (2009)

Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation
por: Lv, Mingyu, et al.
Publicado: (2015)

Resilience of BST-2/Tetherin structure to single amino acid substitutions
por: Roy, Ian R., et al.
Publicado: (2019)

BST2/Tetherin Inhibits Dengue Virus Release from Human Hepatoma Cells
por: Pan, Xiao-Ben, et al.
Publicado: (2012)

Membrane-Associated RING-CH Proteins Associate with Bap31 and Target CD81 and CD44 to Lysosomes
por: Bartee, Eric, et al.
Publicado: (2010)

Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction
por: Le Tortorec, Anna, et al.
Publicado: (2011)

Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism
por: Arias, Juan F., et al.
Publicado: (2011)

Tetherin/BST-2 Antagonism by Nef Depends on a Direct Physical Interaction between Nef and Tetherin, and on Clathrin-mediated Endocytosis
por: Serra-Moreno, Ruth, et al.
Publicado: (2013)

Feline tetherin (BST-2) restricts feline immunodeficiency virus release but not spreading infection
por: Dietrich, Isabelle, et al.
Publicado: (2011)

Comparative study on the effect of human BST-2/Tetherin on HIV-1 release in cells of various species
por: Sato, Kei, et al.
Publicado: (2009)

BST2/Tetherin Overexpression Modulates Morbillivirus Glycoprotein Production to Inhibit Cell–Cell Fusion
por: Kelly, James T., et al.
Publicado: (2019)

Limiting Respiratory Viral Infection by Targeting Antiviral and Immunological Functions of BST‐2/Tetherin: Knowledge and Gaps
por: Berry, Kayla N., et al.
Publicado: (2018)

Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection
por: Li, Sam X., et al.
Publicado: (2016)

The avian influenza virus PA segment mediates strain-specific antagonism of BST-2/tetherin
por: Narkpuk, Jaraspim, et al.
Publicado: (2018)

Multi-functional BST2/tetherin against HIV-1, other viruses and LINE-1
por: Zhao, Yifei, et al.
Publicado: (2022)

The Nef Protein of the Macrophage Tropic HIV-1 Strain AD8 Counteracts Human BST-2/Tetherin
por: Giese, Sebastian, et al.
Publicado: (2020)

The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu
por: Andrew, Amy J, et al.
Publicado: (2009)

Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2
por: Jia, Bin, et al.
Publicado: (2009)

Endogenous Murine BST-2/Tetherin Is Not a Major Restriction Factor of Influenza A Virus Infection
por: Londrigan, Sarah L., et al.
Publicado: (2015)

Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin
por: Santos, Rodrigo I., et al.
Publicado: (2023)

Aberrant Regulation of the BST2 (Tetherin) Promoter Enhances Cell Proliferation and Apoptosis Evasion in High Grade Breast Cancer Cells
por: Sayeed, Aejaz, et al.
Publicado: (2013)

The ESCRT-0 Component HRS is Required for HIV-1 Vpu-Mediated BST-2/Tetherin Down-Regulation
por: Janvier, Katy, et al.
Publicado: (2011)

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment
por: Hauser, Heiko, et al.
Publicado: (2011)

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment
por: Hauser, Heiko, et al.
Publicado: (2010)

Immunoelectron Microscopic Evidence for Tetherin/BST2 as the Physical Bridge between HIV-1 Virions and the Plasma Membrane
por: Hammonds, Jason, et al.
Publicado: (2010)

Long Non-Coding RNA BST2/BISPR is Induced by IFN and Regulates the Expression of the Antiviral Factor Tetherin
por: Barriocanal, Marina, et al.
Publicado: (2015)

CRISPR-mediated activation of endogenous BST-2/tetherin expression inhibits wild-type HIV-1 production
por: Zhang, Yanzhao, et al.
Publicado: (2019)

Zn‐Induced Interactions Between SARS‐CoV‐2 orf7a and BST2/Tetherin
por: Petrosino, Maria, et al.
Publicado: (2021)

ATG5 selectively engages virus-tethered BST2/tetherin in an LC3C-associated pathway
por: Judith, Delphine, et al.
Publicado: (2023)

Viral hijacking of the host ubiquitin system to evade interferon responses
por: Viswanathan, Kasinath, et al.
Publicado: (2010)

A rare missense variant abrogates the signaling activity of tetherin/BST-2 without affecting its effect on virus release
por: Sauter, Daniel, et al.
Publicado: (2013)

βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin
por: Song, Yul Eum, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uf1abi43nsguadrsr0orvtji64